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Abstract
Background: The clonal transmission of lineage-specific DNA methylation patterns in a mammalian genome
during the cellular division is a crucial biological process controlled by the DNA methyltransferase Dnmt1, mainly.
To investigate possible dynamic mechanisms of DNA methylation inheritance during the cell cycle, we used a
Proximity Ligation In Situ Assay (P-LISA) to analyze the kinetic of formation and DNA recruitment of Dnmt1-
including complexes.
Results: P-LISA, sequential chromatin immunoprecipitation and quantitative methylation specific PCR revealed that
the Dnmt1/PCNA/UHRF1-including complexes are mainly formed and recruited on DNA during the S-phase of cell
cycle, while the formation and the DNA recruitment of several Dnmt1/transcription factors-including complexes are
not S-phase dependent but are G0/G1 and/or G2/M phases dependent.
Conclusion: Our data confirm that DNA methylation inheritance occurs in S-phase, and demonstrate that DNA
methylation inheritance can also occur in G0/G1 and G2/M phases of the cell cycle.
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Background
DNA methylation playing a crucial role in the regulation
of gene transcription, genomic imprinting, genomic sta-
bility, and × chromosome inactivation, its inheritance is
essential for the cellular biology and viability because
aberrant DNA methylation and targeted disruption of
DNA methyltransferase enzymes result in tumorigeni-
city, lethality or mitotic catastrophe [1-5]. We and
others have recently demonstrated that the majority of
genomic methylation inheritance is catalyzed by the
Dnmt1/PCNA/UHRF1-including complex since its dis-
ruption promote global DNA hypomethylation [4,6-8].
Nevertheless, other Dnmt-including complexes can cata-
lyze the genomic DNA methylation inheritance. More
generally, the majority of Dnmt1-including complexes
are implicated in the inheritance of DNA methylation
since Dnmt1 is responsible for maintaining genomic
methylation, even if other Dnmt-including complexes
could catalyzed maintenance DNA methylation reactions
[9,10].
Recently, we reported that the Dnmt1/transcription
factors-including complexes act as an alternative
mechanism of DNA methylation inheritance to the
mechanism performed by the Dnmt1/PCNA/UHRF1-
including complex [11]. To complement this point, we
here investigated the dynamic of formation of several of
these complexes during the cell cycle. Proximity Liga-
tion In Situ Assay (P-LISA) and ApoTome technology
c o n f i r m e dt h a tt h eD n m t 1 / P C N A / U H R F 1 - i n c l u d i n g
complex is mainly formed and recruited on DNA during
the S-phase of cell cycle, while the formation and the
recruitment on DNA of the six considered Dnmt1/tran-
scription factors-including complexes are not S-phase
dependent obligatory. In addition and more particularly,
sequential chromatin immunoprecipitation experiments
(reChIP) and quantitative methylation specific PCR
(qMSP) revealed that Dnmt1/UHRF1 mainly promoted
the methylation of the caspase4 gene during the S
phase, that Dnmt1/YY1 mainly promoted the methyla-
tion of the DR5 gene during the G2/M phase, and that
Dnmt1/Ets1 mainly promoted the methylation of the
caspase1 gene during the G0/G1 phase.
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Characterization of cell cycle arrest
To analyze the formation and the recruitment on DNA
of the considered Dnmt1-including complexes, U251
cells were blocked into the different cell cycle phases by
using serum deprivation and the thymidine, nocodazole
or taxol treatments. As expected, cell cycle phase analy-
sis indicated that serum deprivation mainly blocked cells
in G0/G1 phases, thymidine treatment mainly blocked
cells in S phase nocodazole treatment mainly blocked
cells in G2/M phase, while taxol treatment mainly
blocked cells in G2/M phase and more specifically in M
phase since taxol blocks metaphasis/anaphasis transition
of mitosis (Table 1) [12].
Dynamic of the Dnmt1-including complexes into cell
cycle
As already used to analyze the formation of the Dnmt1/
PCNA-including complexes and its recruitment on
DNA in glioma cells, we used Proximity Ligation In Situ
Assay (P-LISA) and ApoTome technology to dissect the
dynamic of formation of the Dnmt1/PCNA-including
complex and its recruitment on DNA during the differ-
ent phases of cell cycle [4]. Thus, we noted that the
Dnmt1/PCNA-including and Dnmt1/UHRF1-including
complexes were mainly formed and recruited on DNA
during the S-phase of cell cycle (Figures 1A and 1B).
Among the transcription factors already described as
been potential partners of interactions of Dnmt1, we
focused our analysis on the dynamic of formation and
recruitment on DNA of 6 Dnmt1/transcription factors-
including complexes. P-LISA experiments indicated that
the Dnmt1/p53-including and Dnmt1/YY1-including
complexes were mainly formed and recruited on DNA
during the G2/M phases of cell cycle (Figure 2A). The
Dnmt1/Sp1-including and Dnmt1/PPARg-including
complexes were mainly formed and recruited on DNA
during the G0/G1 and G2/M phases of cell cycle. The
Dnmt1/Ets1-including complexes were mainly formed
and recruited on DNA during the G0/G1 phase of cell
cycle, while the Dnmt1/E2F3-including complexes were
mainly formed and recruited on DNA during the S and
G2/M phases of cell cycle. Interestingly, all these data
indicated that the formation and the recruitment on
DNA of the complex(es) including the Dnmt1, PCNA
and/or UHRF1 proteins mainly occur during the S
phase of the cell cycle, while the formation and the
recruitment on DNA of the Dnmt1/transcription factor-
including complexes are not specific of one phase of the
cell cycle (Figure 2B).
Dynamic of the Dnmt1-including complexes and proteins
expression during the different cell cycle phases
Next, we hypothesized that the kinetics of the interac-
tions existing between Dnmt1 and its considered part-
ners could be due to the putative changes in the
expression level and/or of subcellular localization of
these proteins. To validate these points, we performed
western blots analyses using nuclear and cytosolic
extracts from cells blocked in the different cell cycle
phases. Actin and Lamin-B1 were used as cytosol and
nuclear internal controls, respectively. No change in the
expression and subcellular localization was observed for
Dnmt1, UHRF1, Sp1 and E2F3 (Figures 3A and 3B).
YY1 expression was higher in G2/M phase supporting
the idea that the Dnmt1/YY1 interactions mainly occur
in G2/M phase. Ets1 expression was higher in G0/G1
phase supporting the fact that Dnmt1/Ets1 interaction
mainly occurs in G0/G1 phase. PCNA expression was
higher in S phase supporting the fact that Dnmt1/
PCNA interaction mainly occurs in S phase. With
regards to p53, we noted that the p53 expression
increased during the cell cycle progression. This obser-
vation can explain why Dnmt1/p53 interaction was
higher in G2/M phase. Western blot analyses also
revealed that the nuclear expression of PPARg decreased
during the cell cycle progression. This point supports
the fact that the number of the Dnmt1/PPARg dots seen
in G0/G1 phase was superior to that seen in S phase,
but not the observation that the number of the Dnmt1/
PPARg dots seen in S phase was superior to that seen in
G2/M phase. Without explaining all variations of
Dnmt1/partner-X interactions, the variations in the
expression level of the partners of Dnmt1 appears as a
rational explanation for the dynamic of the Dnmt1/part-
ner-X interactions existing during the different cell cycle
phases.
Dnmt1/UHRF1, Dnmt1/YY1 and Dnmt1/Ets1 complexes
are mainly recruited on genes during the S, G2/M and
G0/G1 phases, respectively
Consistent with our last results, we then hypothesized
that the complexes including the Dnmt1/Ets1, Dnmt1/
UHRF1 and Dnmt1/YY1 proteins were mainly recruited
on DNA during the G0/G1, S or G2/M phases, respec-
tively. To cure these points, we analyzed by sequential
chromatin immunoprecipitation (reChIP)
Table 1 Characterization of cell cycle arrest.
Serum dep Thymidine Noco Taxol
G0/G1 93.2 ± 4.7 10.2 ± 3.7 9.8 ± 4.7 0.2 ± 0.3
S 2.6 ± 0.8 59.7 ± 2.7 10.8 ± 3.7 2.8 ± 1.7
G2/M 2.6 ± 1.7 30.2 ± 3.5 78.9 ± 3.5 81.2 ± 4.1
U251 cells were treated by serum deprivation (72 h) or by thymidine (2 mM,
24 h), nocodazole (100 ng/mL, 24 h) or taxol (150 ng/mL, 24 h) previous to
perform cell cycle analysis by using the NucleoCounter NC-3000™ Kit,
Chemometec, France). Data illustrate the mean and standard deviation
obtained from 3 independent experiments.
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Figure 1 Dynamic of the formation and of the recruitment on DNA of the Dnmt1/PCNA-including complexes during the cell cycle. (A)
ApoTome view of the Dnmt1/PCNA dots in U251 cells during the different phases of the cell cycle. Red dots symbolize Dnmt1/PCNA dots.
Nucleus/DNA are stained in blue via the use of DAPI. Graph (mean ± SEM) illustrating the number of Dnmt1/PCNA dots per nucleus in U251
cells during the different phases of the cell cycle. The number of Dnmt1/PCNA interactions is calculated from the analysis of, at least, 50 nucleus
in three independent experimentations. (B) Graph (mean ± SEM) illustrating the number of Dnmt1/UHRF1 interactions per nucleus in U251 cells
during the different phases of the cell cycle. The number of Dnmt1/UHRF1 interactions is calculated from the analysis of, at least, 50 nucleus in
three independent experimentations.
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Figure 2 Dynamic of the formation and of the recruitment on DNA of the Dnmt1/transcription factor-including complexes during the
cell cycle. (A) Graph (mean ± SEM) illustrating the number of Dnmt1/transcription factor dots per nucleus in U251 cells during the different
phases of the cell cycle. The number of Dnmt1/transcription factor interactions is calculated from the analysis of, at least, 50 nucleus in three
independent experimentations. (B) Schematic representation of the dynamic of the Dnmt1-including complexes during the cell cycle.
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Page 4 of 11experimentations the co-recruitment of Dnmt1/Ets1,
Dnmt1/UHRF1 and Dnmt1/YY1 on specific genes dur-
ing the different phases of the cell cycle. Thus, after a
blockade of cells in the different cell cycle phases, chro-
matin was immunoprecipitated with an antibody direc-
ted against Dnmt1 in the first time and with an
antibody directed against Ets1, UHRF1 or YY1 in a sec-
ond time, an antibody directed against GFP was used as
control. For the targeted genes, we focused our analyses
on genes coding for effectors or regulators of apoptosis
since our group is involved in the analysis of mechan-
isms modulating apoptosis. As such, we analyzed the
co-recruitment of Dnmt1/Ets1, Dnmt1/UHRF1 and
Dnmt1/YY1 on caspase-1 gene (a target of Ets1), cas-
pase-4 gene and DR5 gene (a target of YY1) [13,14]. As
shown in Figure 4, we observed that the Dnmt1/UHRF1
complex was mainly recruited on the caspase1 gene in
G0/G1 phase and that the recruitment of Dnmt1/
UHRF1 and Dnmt1/YY1 on the caspase4 and DR5 gene
mainly occurred during the S and G2/M phases, respec-
tively. Associated with our previous data, these last
results strongly support the idea that the Dnmt1/
UHRF1, Dnmt1/YY1 and Dnmt1/Ets1 complexes were
mainly formed and recruited on DNA during the S, G2/
M and G0/G1 phases of the cell cycle, respectively.
Maintenance of DNA methylation can occur after cellular
division
The fact that the formation and the recruitment on
DNA of the Dnmt1/Partner-X occurs in different phases
suggests that the inheritance of DNA methylation on its
targeted genes by this type of complex can occur after
the cellular division or that DNA can exist under a
hemi-methylated status in one or several cell cycle
phases. Thus, we compared, the methylation status of
caspase1, caspase4 and DR5 genes during the different
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Figure 3 Dynamic of expression and subcellular localization of the Dnmt1 and its partners of interaction during the cell cycle.( A )
Pictures illustrate the results obtained after Western blot analyses. Nuclear (nuc.) and cytosolic (cyto.) were obtained by using the Nuclear Extract
Kit (Active Motif, France). 30 μg and 50 μg of nuclear and cytosolic extracts were used for the western blot analysis concerning the Dnmt1,
UHRF1, Sp1, E2F3, YY1, p53, Ets1, PCNA and PPARg proteins. 20 μg of nuclear and cytosolic extracts were used for the western blot analysis
concerning the actin and lamina-B1 proteins. (B) Graphs illustrate the relative expression of indicated proteins in nuclear fraction i.e. the results
obtained from the densitometric analyses of western blot (Fusion Fx7 Imager, Fisher Scientific, France and ImageJ software). Lamina-B1 was used
as internal control.
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Page 5 of 11cell cycle phases. Methylated DNA Collected (MeDCol)
and hemi-Methylated DNA Isolated (hemi-MeDIs) were
used to determine the status of methylation or hemi-
methylation of the considered genes since DNA was
purified using recombinant proteins having the capacity
to specifically bind methylated (MBD2b/MBD3L1 pro-
tein complex, according to Active Motif kit) or hemi-
methylated DNA (UHRF1). The hemi-MeDIs and MeD-
Col indicated that caspase1 gene was mainly hemi-
methylated in S and G2/M phases and was mainly
methylated in G0/G1 phase since maximum of amplifi-
cation of caspase1 gene was observed when PCR were
realized from DNA isolated by hemiMeDIs and MeDCol
issue to cells blocked in S and G2/M, and G0/G1
phases, respectively (Figure 5). Similar experiments indi-
cated that caspase4 gene was hemi-methylated in S
phase and methylated in G0/G1 and G2/M phases, and
DR5 was hemi-methylated in S phase and methylated in
G0/G1 phase (Figure 5).
Consistently with results obtained from reChIP experi-
ments, our data indicated that the maintenance of
methylation of capsase1 gene occurs during G0/G1
phase and implicates Dnmt1/Ets1, the maintenance of
methylation of capsase4 gene occurs during S phase and
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Figure 4 ReChiP experiments analysis the recruitment on the caspase1, caspase4,a n dDR5 genes of the Dnmt1/Ets1, Dnmt1/UHRF1,
and complexes during the cell cycle. Sequential chromatin ImmunoPrecipitation (reChIP) are used to analyze the recruitment of Dnmt1,
UHRF1 and transcription factor on the considered genes. Results are expressed as enrichment relative to input and corrected for GFP control
levels. The results are averages of at least three independent experiments with error bars indicating standard deviation.
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Page 6 of 11implicates Dnmt1/UHRF1, and that the maintenance of
methylation of DR5 gene occurs during G2/M phase
and implicates Dnmt1/YY1.
Discussion
During the last decades, several studies have analyzed
the crosstalk existing between the mechanism of DNA
methylation and cell cycle since DNA replication, occur-
ring during S phase, gives birth to a hemi-methylated
DNA of which the neo-synthesized strand must be
methylated to assure the transmission of the DNA
methylation during the cell division. Thus, supported by
this idea, by the preferential activity of Dnmt1 for hemi-
methylated DNA, and by the description of the interac-
tion between Dnmt1, PCNA (a protein of the DNA
replication machinery) and UHRF1 (a protein binding
hemi-methylation DNA), it has been proposed that the
inheritance of DNA methylation by the Dnmt1/PCNA/
UHRF1-including complex occurs during the S phase of
cell cycle [6,8,15,16]. However, the idea that the DNA
methylation occurs during S phase, although confirmed
by several publications, is challenged and discussed by
the fact that the maintaining of DNA methylation could
be catalyzed in other phases of the cell cycle. Besides,
our data echoes this situation since we observed that
the Dnmt1/PCNA-including complexes were mainly
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Figure 5 Methylation status of the caspase1, caspase4 and DR5 during the cell cycle. DNA: sonicated DNA (input), Ctrl: hemiMeDIs realized
in absence of His-UHRF1 on column, hemiMeDIs: hemi-methylated DNA Isolated, MeDCol: Methylated DNA collected. The results are averages of
at least three independent experiments with error bars indicating standard deviation.
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Page 7 of 11formed and recruited on DNA during the S phase of cell
cycle, while the formation and the DNA recruitment of
the Dnmt1/transcription factor-including complexes can
occur during different phases of the cell cycle. The fact
that the formation and the recruitment on DNA of
some Dnmt1/transcription factor-including complexes
(such as the Dnmt1/p53-including or Dnmt1/YY1-
including complexes) mainly occur during G2/M phases
confirms the idea that Dnmt1 can load chromatin dur-
ing the G2 and M phases [17]. Consistently with this
point and with the fact that the maintenance of DNA
methylation pattern of certain genes can be catalyze by
the Dnmt1/transcription factor complexes, it appears
that the inheritance of DNA methylation mainly
requires Dnmt1 but not its interaction with the replica-
tion machinery such as already reported in the literature
[11,18]. Moreover, the dynamism of the Dnmt1/PCNA
interaction during the cell cycle also reinforces the tran-
sient nature of this interaction [19]. Similarly, the dyna-
mism of the considered Dnmt1/transcription factor
interactions suggests that these interactions are also
transient. Thus, the description of dynamic mechanisms
of DNA methylation inheritance during the cell cycle by
the considered Dnmt1-including complexes increases
our understanding of the orchestration of different
Dnmt-including complexes into the process of DNA
methylation inheritance. More particularly, after the
work published by Métivier et al., our work completes
and provides new perspectives into the investigation of
the cyclical DNA methylation process [20].
The observation that the interaction level of Dnmt1
with certain of its interaction partner is parallel to the
expression level of this partner, provides a rational
explanation for the existence a dynamic for Dnmt1/part-
ner-X interaction occurring during the cell cycle. Con-
cerning the kinetics of expression of the PCNA, YY1,
p53, Ets1 and PPARg proteins, our data revealed the
existent of significant but weak variations (2.8 fold for
the maximum). The elevated expression of PCNA in S
phase seems make sense with its function during cell
cycle phase. The elevated expression of Ets1 in G0/G1
phase and of p53 and YY1 in G2/M phase appears con-
sistent with the description of their activation/function
during these cell cycle phases [21-24]. Concerning the
impact of nocodazole on p53, our data indicate that ele-
vation of p53 expression was not associated with a
nocodazole-induced up-expression of p53 since the pre-
sence of cycloheximide (an inhibitor of protein synth-
esis) not changes the p53 expression (Additional file 1).
The variation of the protein expression does not
explain all the dynamics of the Dnmt1/partner-X inter-
actions occurring during the cell cycle. A description of
other causes of the dynamic of Dnmt1/partner-X
interaction occurring during the cell cycle is an ongoing
subject in our laboratory. We have also the project to
develop a global analysis identifying a maximum of
genes of which the methylation inheritance occurs in
the different cell cycle phases. Nevertheless, despite its
limitation to low numbers of genes and on Dnmt1-
including complex taken into consideration, our data
provide an interesting proof of concept of the kinetics
of DNA methylation inheritance by the Dnmt1-includ-
ing complexes during the cell cycle.
The fact that the formation and the recruitment on
DNA of some Dnmt1/transcription factor-including
complexes such as the Dnmt1/Ets1-including complexes
mainly occur in G0/G1 phases suggests that the inheri-
tance of DNA methylation on the targeted genes by this
type of complex can occur after the cellular division. In
other terms, this point suggests that the cellular division
can occur with a significant and certain stock of hemi-
methylated DNA i.e. that the cellular division can occur
in absence of total inheritance of DNA methylation hall-
mark characterizing the “mother cell”.B e s i d e s ,o u rd a t a
illustrate this point by showing that the Dnmt1/Ets1
complex promotes the maintenance of the caspase1
gene in G0/G1 phases i.e. after the cellular division.
Finally, the identification of the Dnmt1/Ets1, Dnmt1/
UHRF1 and Dnmt1/YY1 as actors of the DNA methyla-
tion of the caspase1, caspase4 and DR5 genes respec-
tively reinforces our understanding of the epigenetic
regulation of genes coding for proteins playing a role of
actor or regulator of the apoptotic program [25].
Besides, the crucial role played by the Dnmt1 into these
processes is also supported by the fact that the Dnmt1
invalidation abrogated the methylation of the caspase1,
caspase4 and DR5 genes [26]. In addition, the identifica-
tion of the Dnmt1 as a crucial actor of the methylation
of the caspase1, caspase4 and DR5 genes suggests that
the use of Dnmt1 inhibitor such as the MG-98 (a sec-
ond-generation Dnmt1-specific anti-sense inhibitor cur-
rently in phase II clinical trials) or the SGI-1027 could
be used to promote or restore the sensitivity of apopto-
sis induced by the TNF or TRAIL systems in glioma
[27,28].
Conclusion
Our data confirm that DNA methylation inheritance
occurs in S-phase, and clearly demonstrate that DNA
methylation inheritance can also occur in G0/G1 and
G2/M phases of the cell cycle. Thus, and despite its lim-
itation to low number of genes and on Dnmt1-including
complex taken into consideration, our data provide, for
the first time, an interesting proof of concept of the
kinetics of DNA methylation inheritance by the Dnmt1-
including complexes during the cell cycle.
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Proximity ligation in situ assay (P-LISA)
Cells were fixed with 4% paraformaldehyde in PBS
pH7.4 for 15 min at room temperature. Permeabilization
is performed with PBS containing 0.5% Triton 100 × 4
for 20 min at room temperature and staining were rea-
lized according to manufacturer’s instructions (Olink
Bioscience) [29]. Fluorescence was visualized by using
the Axiovert 200 M microscopy system (Zeiss, Le Pecq,
France) with ApoTome module (X63 and numerial
aperture 1.4). Pictures acquisition was realized in struc-
tured illumination microscopy [30]. Thus, the lateral
resolution (rl) is, according to the Rayleigt criteria: rl =
0.61l/NA (l: wavelength; NA: numerical aperture of the
objective), and the axial resolution, in ApoTome, is
defined by the full-width half maximum (FWHMz)
FWHM(z)=
3.83
16π
·
λ × 10−3
n · sin
2 α
2

¯ v

1 − ¯ v
2

In this equation, l is the emission wavelength, n is the
index of medium refraction, ν is the frequency and a is
the angle of opening of the objective as previously
described [31].
After decovolving (3.5 Huygens Essential software
(SVI)), 3D view was obtained by using Amira.4.1.1 pro-
gram. Finally, the images were analyzed by using the
freeware “BlobFinder available for download from
http://www.cb.uu.se/~amin/BlobFinder. Thus, we
obtained either number of signals per nuclei since nuclei
can be automatically identified. In other terms, the use
of this program participates to the normalization, stan-
dardization, reproducibility and to the definition of the
cut off signal to accept/quantify or not a dot.
Chromatin ImmunoPrecipitation (ChIP) and Re-ChIP
experiments
Briefly, chromatin was purified from cells after cross-
linking with 1% formaldehyde for 10 min at room tem-
perature. ChIP and Re-ChIP assays were performed with
the ChIP-IT™ and Re-ChIP-IT™ kit (ActiveMotif,
France) with indicated antibodies and primers. In ChIP
and reChIP assays, quantitative PCRs (MX4000 system
and the Brilliant SYBR Green QPCR Core Reagent Kit)
were performed on 2 μlo fi n p u t ,C h I Po rr e C h I Ps a m -
ple DNA. The relative levels of the fragments of interest
in the immunoprecipitated DNA were determined from
the threshold cycle (CT) for each PCR. To ensure the
reliability of our ChIP and reChIP data, two control
samples specific for the ChIP and reChIP experiments
have been included: the input sample (indicative of the
presence and amount of chromatin used in the ChIP
reaction) and the control antibody (GFP antibody)
sample (indicative of the amount of background signal
generated by the chromatin preparations and ChIP pro-
cedure). The calculations of the relative enrichment
values were as described below. (i) We normalized the
quantitative PCR signals obtained from the immunopre-
cipitated ChIP sample to the input sample, i.e., CT
input - CT ChIP. The PCR efficiency, corresponding to
the different sets of primers used in our quantitative
PCR, was then raised to the power of this CT difference,
i.e., (primer PCR efficiency)(CT input - CT ChIP). (ii)
The enrichment (n-fold) of the immunoprecipitated
sequence of interest was obtained by normalizing the
values to the ChIP background (relative to IP GFP anti-
body). (iii) To ensure that the observed binding of the
tested proteins reflect specific binding to the considered
promoter, we also amplified an unrelated control region
in a quantitative PCR. The relative enrichment values
were calculated by dividing the enrichment (n-fold)
derived from the sequence of interest by the signal
d e r i v e df r o mt h i sc o n t r o ll o c u s( u n r e l a t e dc o n t r o l
region).
DNA extraction and methylation status analyses
DNA was extracted by using the QiaAmp DNA mini Kit
(Qiagen, France). DNA was sonicated by using a Biorup-
tor Sonicator (Diagenode, France). Methylated DNA
Collected (MeDCol) was realized by using the Methyl-
Collector™ Ultra kit (Active Motif, France). Hemi-
Methylated DNA Isolated (hemiMeDIs) was realized by
using his-tagged UHRF1 protein to isolated hemimethy-
lated DNA. Briefly, 2 μg of His-UHRF1 were loading on
Handee™ Spin Column containing 50 μl of Immobilized
Cobalt Chelate resin (ProFound™ Pull-Down PolyHis
Protein:Protein Interaction Kit Pierce, Thermo Scientific,
France). Next, 100 ng of sonicated genomic DNA was
incubated on previous tube/column, on a rotisserie sha-
ker for 1 hour at 4°C in binding buffer issue to the
MethylCollector™ Ultra kit (Active Motif, France).
Washes, recovery of methylated DNA fragments, DNA
clean-up steps were performed such as described in
MethylCollector™ Ultra kit (Active Motif, France).
Finally, methylated and hemi-methylated DNA was ana-
lyzed by qPCR. To evaluate the relative enrichment of
target sequences, we normalized (for each amplicon
tested) the Ct of the MeDCOl/HemiMeDIs fraction to
the Ct of the input (ΔCt). Subsequently we normalized
the ΔCt of each target sequence to the ΔCt of an
unmethylated control sequence (ΔΔCt). Finally, we cal-
culated the relative enrichment E = 2
ΔΔCt.
Western blot
In brief, proteins were size fractionated by sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis. Proteins
were transferred onto nitrocellulose or PVDF
Hervouet et al. Cell Division 2012, 7:5
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Page 9 of 11membrane. Saturation and blotting were realized by
using SNAP i.d™ Protein Detection System (Millipore,
France). The detection of proteins was performed using
ECL™(Amersham Biosciences) and/or SuperSignal west
femto Maximum Sensitivity (Pierce) chemilumenscence
reagents.
Supplemental data
Antibodies and primers are listed in additional file 2 and
3.
Additional material
Additional file 1: List of antibodies.
Additional file 2: List of primers.
Additional file 3: Effect of cycloheximide and/or nocodazole
treatment on the p53 expression. Western blot analyses indicated that
the cycloheximide treatment unchanged the elevation of p53 expression
seen when U251 cells were treated with nocodazole.Thus, we supposed
that nocodazole treatment not activated the synthesis of p53 and that
the elevation of p53 in nocodazole-treated cells was due to an
accumulation of p53.
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